0001415889-19-000897.txt : 20190805 0001415889-19-000897.hdr.sgml : 20190805 20190805160016 ACCESSION NUMBER: 0001415889-19-000897 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190801 FILED AS OF DATE: 20190805 DATE AS OF CHANGE: 20190805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elkins David V CENTRAL INDEX KEY: 0001451604 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 19998598 MAIL ADDRESS: STREET 1: C/O BECTON, DICKINSON AND COMPANY STREET 2: 1 BECTON DRIVE CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 form4-08052019_040802.xml X0306 4 2019-08-01 0000816284 CELGENE CORP /DE/ CELG 0001451604 Elkins David V C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 false true false false EVP, CHIEF FINANCIAL OFFICER Common Stock 2019-08-01 4 M 0 24947 0 A 24947 D Common Stock 2019-08-01 4 F 0 11039 93.05 D 13908 D Common Stock 195 I 401(k) Plan Restricted Stock Unit 2019-08-01 4 M 0 24947 0 D Common Stock 24947 49895 D One-third of the restricted stock units granted to the reporting person on August 1, 2018 have vested and settled for shares of the Company's common stock. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The balance of the restricted stock units will vest as follows: 24,947 shares on August 1, 2020 and 24,948 shares on August 1, 2021. Vested shares will be delivered to the reporting person promptly after the vesting date. The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan. /s/ Mark J. Alles, Attorney-in-Fact 2019-08-05 EX-24 2 ex24-08052019_040802.htm ex24-08052019_040802.htm

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Mark J. Alles, Jonathan P. Biller and Alexis M. Pinto the undersigned’s true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Celgene Corporation (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each of the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 22nd day of April, 2019.

/s/ David V. Elkins

Name: David V. Elkins